WallStreetZenWallStreetZen

NASDAQ: CRNX
Crinetics Pharmaceuticals Inc Stock Ownership - Who owns Crinetics Pharmaceuticals?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Crinetics Pharmaceuticals Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Richard Scott StruthersCEO;Pres2026-08-076,542$15.29
$100.03kBuy
Richard Scott StruthersCEO;Pres2026-08-073,969$25.19
$99.98kBuy
Richard Scott StruthersCEO;Pres2026-08-074,995$20.02
$100.00kBuy
Richard Scott StruthersCEO;Pres2026-08-074,422$22.61
$99.98kBuy
Coelho Rogerio VivaldiDirector2026-07-023,000$40.00
$120.00kSell
Stephanie OkeyDirector2026-06-176,292$35.62
$224.12kSell
Stephanie OkeyDirector2026-06-17608$36.22
$22.02kSell
Jeff E. KnightChief Dev. Operating Officer2026-04-089,624$20.02
$192.67kBuy
Jeff E. KnightChief Dev. Operating Officer2026-04-0885,163$40.10
$3.42MSell
Jeff E. KnightChief Dev. Operating Officer2026-04-0849,474$23.98
$1.19MBuy

1 of 5

CRNX insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when CRNX insiders and whales buy or sell their stock.

CRNX Shareholders

What type of owners hold Crinetics Pharmaceuticals Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Perceptive Advisors LLC7.46%7,908,985$667.83MInsider
Richard Scott Struthers3.40%3,606,921$304.57MInsider
Vivo Capital VIII LLC0.77%813,904$68.73MInsider
5am Ventures IV LP0.41%439,144$37.08MInsider
Versant Venture Capital V LP0.21%226,025$19.09MInsider
Ajay Madan0.17%176,995$14.95MInsider
Moody Aldrich Partners LLC0.14%146,077$12.33MInstitution
Stephen F. Betz0.13%137,101$11.58MInsider
Wendell Wierenga0.12%122,071$10.31MInsider
Wendall Wierenga0.11%116,146$9.81MInsider

1 of 3

CRNX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
CRNX0.06%13.33%Net SellingNet Buying
SYRE0.06%24.50%Net SellingNet Selling
PCVX0.05%13.62%Net SellingNet Selling
IMVT0.03%57.74%Net BuyingNet Selling
ABVX0.02%0.00%
View Top Biotech Stocks

Crinetics Pharmaceuticals Stock Ownership FAQ

Who owns Crinetics Pharmaceuticals?

Crinetics Pharmaceuticals (NASDAQ: CRNX) is owned by 0.06% institutional shareholders, 13.33% Crinetics Pharmaceuticals insiders, and 86.60% retail investors. Perceptive Advisors LLC is the largest individual Crinetics Pharmaceuticals shareholder, owning 7.91M shares representing 7.46% of the company. Perceptive Advisors LLC's Crinetics Pharmaceuticals shares are currently valued at $669.89M.

If you're new to stock investing, here's how to buy Crinetics Pharmaceuticals stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.